Investor Relations

Press Releases

All Releases
View Summary OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP)
Dec 15, 2014
PDF 16.9 KB
View Summary OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference
Dec 3, 2014
PDF 8.5 KB
View Summary OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference
Nov 13, 2014
PDF 7.7 KB
View Summary OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States
Nov 10, 2014
PDF 53.1 KB
View Summary OPKO To Hold Conference Call on November 10, 2014
Nov 7, 2014
PDF 10.2 KB
View Summary OPKO Announces Third Quarter Operating and Financial Results
Nov 7, 2014
PDF 24.2 KB
View Summary Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve
Oct 9, 2014
PDF 12.8 KB
View Summary OPKO Health Supports National Prostate Cancer Council Legislation
Sep 29, 2014
PDF 12.0 KB
View Summary OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints
Sep 23, 2014
PDF 15.6 KB
View Summary OPKO Launches the 4Kscore Test in Europe
Sep 15, 2014
PDF 12.9 KB
View Summary Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference
Sep 11, 2014
PDF 12.5 KB
View Summary OPKO Licensee TESARO Submits New Drug Application for Rolapitant
Sep 8, 2014
PDF 12.5 KB
View Summary OPKO Announces Second Quarter Operating and Financial Results
Aug 11, 2014
PDF 25.6 KB
View Summary Rayaldee Phase 3 Trial Meets Primary Endpoints
Aug 11, 2014
PDF 16.2 KB
View Summary OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy
Aug 7, 2014
PDF 14.7 KB
View Summary OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014
Aug 7, 2014
PDF 11.2 KB
View Summary OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE
Jul 22, 2014
PDF 12.4 KB
View Summary OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe
Jul 9, 2014
PDF 11.9 KB
View Summary OPKO Granted Patent from European Patent Office for Lagova™
Jun 27, 2014
PDF 10.5 KB
View Summary Strong Data from Lagova™ Phase II Clinical Study Presented during Webcast
Jun 25, 2014
PDF 14.3 KB
Showing 1-20 of 194 Page: 1 2 3 4 5 ... 10  Next 20